Autophagy as a therapeutic target for ischaemia/reperfusion injury? Concepts, controversies, and challenges

Cardiovascular Research

Volumn 94, Issue 2, 2012, Pages 197-205

  Przyklenk, Karin ^a   Dong, Yi ^a   Undyala, Vishnu V ^a   Whittaker, Peter ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autophagy; Myocardial ischaemia; Myocardial reperfusion; Reperfusion injury

Indexed keywords

2 CHLOROCYCLOPENTYLADENOSINE; ADENOSINE A1 RECEPTOR AGONIST; AUTOPHAGY PROTEIN 5; BECLIN 1; CHLORAMPHENICOL HEMISUCCINATE; COLLAGEN; DIAZOXIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MAMMALIAN TARGET OF RAPAMYCIN; MICROTUBULE ASSOCIATED PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; RANOLAZINE; SULFAPHENAZOLE; THAPSIGARGIN; TUNICAMYCIN; UNCLASSIFIED DRUG;

AUTOPHAGOSOME; AUTOPHAGY; CELL DAMAGE; CELL FUNCTION; CELL STRESS; CYTOSOL; ENZYME ACTIVATION; GENE EXPRESSION; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HOUSEKEEPING GENE; HUMAN; IMMUNOMODULATION; MAST CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN AGGREGATION; REPERFUSION INJURY; REVIEW;

ANIMALS; AUTOPHAGY; DISEASE MODELS, ANIMAL; HUMANS; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; MYOCYTES, CARDIAC;

EID: 84860210734     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr358     Document Type: Review

References (80)

1. Schwartz Longacre L, Kloner RA, Arai AE, Baines CP, Bolli R, Braunwald E et al. New horizons in cardioprotection: recommendations from the 2010 national heart, lung, and blood institute workshop. Circulation 2011;124:1172-1179.
2. Hausenloy DJ, Baxter G, Bell R, Botker HE, Davidson SM, Downey J et al. Translating novel strategies for cardioprotection: the Hatter workshop recommendations. Basic Res Cardiol 2010;105:677-686.
3. Braunwald E. Clinical efforts to reduce myocardial infarct size: the next step. J Cardiovasc Pharmacol Ther 2011;16:349-353.
4. Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science 2000;290:1717-1721. (Pubitemid 32004796)
5. Yoshimori T. Autophagy: a regulated bulk degradation process inside cells. Biochem Biophys Res Commun 2004;313:453-458. (Pubitemid 37543608)
6. Shintani T, Klionsky DJ. Autophagy in health and disease: a double-edged sword. Science 2004;306:990-995. (Pubitemid 39482894)
7. Codogno P, Meijer AJ. Autophagy and signaling: their role in cell survival and cell death. Cell Death Differ 2005;12(Suppl. 2):1509-1518. (Pubitemid 41553987)
8. Xie Z, Klionsky DJ. Autophagosome formation: core machinery and adaptations. Nat Cell Biol 2007;9:1102-1109. (Pubitemid 47500484)
9. Mizushima N. Autophagy: process and function. Genes Dev 2007;21:2861-2873. (Pubitemid 350133435)
10. Gustafsson AB, Gottlieb RA. Autophagy in ischemic heart disease. Circ Res 2009;104: 150-158.
11. Dong Y, Undyala VV, Gottlieb RA, Mentzer RM Jr, Przyklenk K. Autophagy: definition, molecular machinery and potential role in myocardial ischemia/reperfusion injury. J Cardiovasc Pharmacol Ther 2010;15:220-230.
12. Nemchenko A, Chiong M, Turer A, Lavandero S, Hill JA. Autophagy as a therapeutic target in cardiovascular disease. J Mol Cell Cardiol 2011;51:584-593.
13. Sciarretta S, Hariharan N, Monden Y, Zablocki D, Sadoshima J. Is autophagy in response to ischemia and reperfusion protective or detrimental for the heart? Pediatr Cardiol 2011;32:275-281.
14. Klionsky DJ, Abeliovich H, Agostinis P, Agrawal DK, Aliev G, Askew DS et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 2008;4:151-175. (Pubitemid 351231180)
15. Gottlieb RA, Mentzer RM. Autophagy during cardiac stress: joys and frustrations of autophagy. Annu Rev Physiol 2010;72:45-59.
16. Hamacher-Brady A, Brady NR, Gottlieb RA. Enhancing macroautophagy protects against ischemia/reperfusion injury in cardiac myocytes. J Biol Chem 2006;281: 29 776-29 787. (Pubitemid 44536987)
17. Hariharan N, Zhai P, Sadoshima J. Oxidative stress stimulates autophagic flux during ischemia/reperfusion. Antioxid Redox Signal 2011;14:2179-2190.
18. Kimura S, Noda T, Yoshimori T. Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy 2007;3:452-460. (Pubitemid 47293726)
19. Yue Z, Jin S, Yang C, Levine AJ, Heintz N. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci USA 2003;100:15 077-15 082. (Pubitemid 37518019)
20. Kuma A, Hatano M, Matsui M, Yamamoto A, Nakaya H, Yoshimori T et al. The role of autophagy during the early neonatal starvation period. Nature 2004;432:1032-1036. (Pubitemid 40052234)
21. Nakai A, Yamaguchi O, Takeda T, Higuchi Y, Hikoso S, Taniike M et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med 2007;13:619-624. (Pubitemid 46828485)
22. Loos B, Engelbrecht AM. Cell death: a dynamic response concept. Autophagy 2009;5: 590-603.
23. Loos B, Genade S, Ellis B, Lochner A, Engelbrecht AM. At the core of survival: autophagy delays the onset of both apoptotic and necrotic cell death in a model of ischemic cell injury. Exp Cell Res 2011;317:1437-1453.
24. Maiuri MC, Zalckvar E, Kimchi A, Kroemer G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 2007;8:741-752. (Pubitemid 47312826)
25. Baines CP. How and when do myocytes die during ischemia and reperfusion: the late phase. J Cardiovasc Pharmacol Ther 2011;16:239-243.
26. Matsui Y, Takagi H, Qu X, Abdellatif M, Sakoda H, Asano T et al. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res 2007;100:914-922. (Pubitemid 46555697)
27. Valentim L, Laurence KM, Townsend PA, Carroll CJ, Soond S, Scarabelli TM et al. Urocortin inhibits Beclin1-mediated autophagic cell death in cardiac myocytes exposed to ischaemia/reperfusion injury. J Mol Cell Cardiol 2006;40:846-852. (Pubitemid 43817043)
28. Gurusamy N, Lekli I, Mukherjee S, Ray D, Ahsan MK, Gherghiceanu M et al. Cardioprotection by resveratrol: a novel mechanism via autophagy involving the mTORC2 pathway. Cardiovasc Res 2010;86:103-112.
29. Yan L, Vatner DE, Kim SJ, Ge H, Masurekar M, Massover WH et al. Autophagy in chronically ischemic myocardium. Proc Natl Acad Sci USA 2005;102:13 807-13 812. (Pubitemid 41377660)
30. French CJ, Taatjes DJ, Sobel BE. Autophagy in myocardium of murine hearts subjected to ischemia followed by reperfusion. Histochem Cell Biol 2010;134:519-526.
31. May D, Gilon D, Djonov V, Itin A, Lazarus A, Gordon O et al. Transgenic system for conditional induction and rescue of chronic myocardial hibernation provides insights into genomic programs of hibernation. Proc Natl Acad Sci USA 2008;105:282-287.
32. Matsui Y, Kyoi S, Takagi H, Hsu CP, Hariharan N, Ago T et al. Molecular mechanisms and physiological significance of autophagy during myocardial ischemia and reperfusion. Autophagy 2008;4:409-415. (Pubitemid 351705136)
33. Kanamori H, Takemura G, Goto K, Maruyama R, Ono K, Nagao K et al. Autophagy limits acute myocardial infarction induced by permanent coronary artery occlusion. Am J Physiol Heart Circ Physiol 2011;300:H2261-H2271.
34. Lemasters JJ. Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction, and aging. Rejuvenation Res 2005;8: 3-5.
35. Hoshino A, Matoba S, Iwai-Kanai E, Nakamura H, Kimata M, Nakaoka M et al. p53-TIGAR axis attenuates mitophagy to exacerbate cardiac damage after ischemia. J Mol Cell Cardiol 2011;52:75-84.
36. Dosenko VE, Nagibin VS, Tumanovska LV, Moibenko AA. Protective effect of autophagy in anoxia-reoxygenation of isolated cardiomyocyte? Autophagy 2006;2:305-306. (Pubitemid 44342376)
37. Sengupta A, Molkentin JD, Yutzey KE. FoxO transcription factors promote autophagy in cardiomyocytes. J Biol Chem 2009;284:28 319-28 331.
38. Sengupta A, Molkentin JD, Paik JH, DePinho RA, Yutzey KE. FoxO transcription factors promote cardiomyocyte survival upon induction of oxidative stress. J Biol Chem 2011;286:7468-7478.
39. McCormick J, Suleman N, Scarabelli TM, Knight RA, Latchman DS, Stephanou A. STAT1 deficiency in the heart protects against myocardial infarction by enhancing autophagy. J Cell Mol Med 2011; doi: 10.1111/j.1582-4934.2011.01323.x. Published online ahead of print March 29, 2011.
40. Gurusamy N, Lekli I, Gorbunov NV, Gherghiceanu M, Popescu LM, Das DK. Cardioprotection by adaptation to ischaemia augments autophagy in association with BAG-1 protein. J Cell Mol Med 2009;13:373-387.
41. Huang C, Yitzhaki S, Perry CN, Liu W, Giricz Z, Mentzer RM Jr et al. Autophagy induced by ischemic preconditioning is essential for cardioprotection. J Cardiovasc Transl Res 2010;3:365-373.
42. Huang C, Andres AM, Ratliff EP, Hernandez G, Lee P, Gottlieb RA. Preconditioning involves selective mitophagy mediated by Parkin and p62/SQSTM1. PLoS One 2011; 6:e20975.
43. Wagner C, Tillack D, Simonis G, Strasser RH, Weinbrenner C. Ischemic postconditioning reduces infarct size of the in vivo rat heart: role of PI3-K, mTOR, GSK-3beta, and apoptosis. Mol Cell Biochem 2010;339:135-147.
44. Yan L, Sadoshima J, Vatner DE, Vatner SF. Autophagy in ischemic preconditioning and hibernating myocardium. Autophagy 2009;5:709-712.
45. Dosenko VE, Nagibin VS, Tumanovskaya LV, Moibenko AA, Vaage J. Postconditioning prevents apoptotic necrotic and autophagic cardiomyocyte cell death in culture. Fiziol Zh 2005;51:12-17.
46. Zhai P, Sciarretta S, Galeotti J, Volpe M, Sadoshima J. Differential roles of GSK-3{beta} during myocardial ischemia and ischemia/reperfusion. Circ Res 2011;109:502-511.
47. Takagi H, Matsui Y, Hirotani S, Sakoda H, Asano T, Sadoshima J. AMPK mediates autophagy during myocardial ischemia in vivo. Autophagy 2007;3:405-407. (Pubitemid 46986358)
48. Nishida K, Kyoi S, Yamaguchi O, Sadoshima J, Otsu K. The role of autophagy in the heart. Cell Death Differ 2009;16:31-38.
49. Wang ZV, Rothermel BA, Hill JA. Autophagy in hypertensive heart disease. J Biol Chem 2010;285:8509-8514.
50. Buss SJ, Muenz S, Riffel JH, Malekar P, Hagenmueller M, Weiss CS et al. Beneficial effects of Mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction. J Am Coll Cardiol 2009;54:2435-2446.
51. Kanamori H, Takemura G, Goto K, Maruyama R, Tsujimoto A, Ogino A et al. The role of autophagy emerging in postinfarction cardiac remodelling. Cardiovasc Res 2011;91: 330-339.
52. Aranguiz-Urroz P, Canales J, Copaja M, Troncoso R, Vicencio JM, Carrillo C et al. Beta(2)-adrenergic receptor regulates cardiac fibroblast autophagy and collagen degradation. Biochim Biophys Acta 2011;1812:23-31.
53. Marchesi C, Essalmani R, Lemarie CA, Leibovitz E, Ebrahimian T, Paradis P et al. Inactivation of endothelial proprotein convertase 5/6 decreases collagen deposition in the cardiovascular system: role of fibroblast autophagy. J Mol Med 2011;89:1103-1111.
54. Ushio H, Ueno T, Kojima Y, Komatsu M, Tanaka S, Yamamoto A et al. Crucial role for autophagy in degranulation of mast cells. J Allergy Clin Immunol 2011;127:1267-1276.
55. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 2002;53:31-47. (Pubitemid 34020764)
56. Keller AM, Clancy RM, Barr ML, Marboe CC, Cannon PJ. Acute reoxygenation injury in the isolated rat heart: role of resident cardiac mast cells. Circ Res 1988;63: 1044-1052. (Pubitemid 19004259)
57. Lock R, Debnath J. Extracellular matrix regulation of autophagy. Curr Opin Cell Biol 2008;20:583-588.
58. Tuloup-Minguez V, Greffard A, Codogno P, Botti J. Regulation of autophagy by extracellular matrix glycoproteins in HeLa cells. Autophagy 2011;7:27-39.
59. Huang C, Liu W, Perry CN, Yitzhaki S, Lee Y, Yuan H et al. Autophagy and protein kinase C are required for cardioprotection by sulfaphenazole. Am J Physiol Heart Circ Physiol 2010;298:H570-H579.
60. Yitzhaki S, Huang C, Liu W, Lee Y, Gustafsson AB, Mentzer RM Jr et al. Autophagy is required for preconditioning by the adenosine A1 receptor-selective agonist CCPA. Basic Res Cardiol 2009;104:157-167.
61. Khan S, Salloum F, Das A, Xi L, Vetrovec GW, Kukreja RC. Rapamycin confers preconditioning-like protection against ischemia/reperfusion injury in isolated mouse heart and cardiomyocytes. J Mol Cell Cardiol 2006;41:256-264. (Pubitemid 44080210)
62. Mukherjee S, Ray D, Lekli I, Bak I, Tosaki A, Das DK. Effects of Longevinex (modified resveratrol) on cardioprotection and its mechanisms of action. Can J Physiol Pharmacol 2010;88:1017-1025.
63. Petrovski G, Das S, Juhasz B, Kertesz A, Tosaki A, Das DK. Cardioprotection by endoplasmic reticulum stress-induced autophagy. Antioxid Redox Signal 2011;14: 2191-2200.
64. Sala-Mercado JA, Wider J, Undyala VV, Jahania S, Yoo W, Mentzer RM Jr et al. Profound cardioprotection with chloramphenicol succinate in the swine model of myocardial ischemia/reperfusion injury. Circulation 2010;122(Suppl. 11):S179-S184.
65. Przyklenk K, Undyala VV, Wider J, Sala-Mercado JA, Gottlieb RA, Mentzer RM Jr Acute induction of autophagy as a novel strategy for cardioprotection: getting to the heart of the matter. Autophagy 2011;7:432-433.
66. Wu YT, Tan HL, Huang Q, Ong CN, Shen HM. Activation of the PI3K-Akt-mTOR signaling pathway promotes necrotic cell death via suppression of autophagy. Autophagy 2009;5:824-834.
67. Hausenloy DJ, Yellon DM. Survival kinases in ischemic preconditioning and postconditioning. Cardiovasc Res 2006;70:240-253.
68. Hausenloy DJ, Yellon DM. Preconditioning and postconditioning: united at reperfusion. Pharmacol Ther 2007;116:173-191. (Pubitemid 47451505)
69. Yang SS, Liu YB, Yu JB, Fan Y, Tang SY, Duan WT et al. Rapamycin protects heart from ischemia/reperfusion injury independent of autophagy by activating PI3 kinase-Akt pathway and mitochondria K(ATP) channel. Pharmazie 2010;65:760-765.
70. Przyklenk K, Maynard M, Darling CE, Whittaker P. Pretreatment with D-myo-inositol trisphosphate reduces infarct size in rabbit hearts: role of inositol trisphosphate receptors and gap junctions in triggering protection. J Pharmacol Exp Ther 2005; 314:1386-1392. (Pubitemid 41206006)
71. Przyklenk K, Maynard M, Whittaker P. Reduction of infarct size with D-myo-inositol trisphosphate: role of PI3-kinase and mitochondrial K(ATP) channels. Am J Physiol Heart Circ Physiol 2006;290:H830-H836.
72. Osipov RM, Robich MP, Feng J, Liu Y, Clements RT, Glazer HP et al. Effect of hydrogen sulfide in a porcine model of myocardial ischemia/reperfusion: comparison of different administration regimens and characterization of the cellular mechanisms of protection. J Cardiovasc Pharmacol 2009;54:287-297.
73. Osipov RM, Robich M, Feng J, Chan V, Clements RT, Deyo RJ et al. Effect of hydrogen sulfide on myocardial protection in the setting of cardioplegia and cardiopulmonary bypass. Interact Cardiovasc Thorac Surg 2010;10:506-512.
74. Ferdinandy P, Schulz R, Baxter GF. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev 2007;59:418-458.
75. Przyklenk K, Maynard M, Darling CE, Whittaker P. Aging mouse hearts are refractory to infarct size reduction with post-conditioning. J Am Coll Cardiol 2008;51:1393-1398. (Pubitemid 351443077)
76. Przyklenk K, Maynard M, Greiner DL, Whittaker P. Cardioprotection with postconditioning: loss of efficacy in murine models of type-2 and type-1 diabetes. Antioxid Redox Signal 2011;14:781-790.
77. Przyklenk K. Efficacy of cardioprotective 'conditioning' strategies in aging and diabetic cohorts: the co-morbidity conundrum. Drugs Aging 2011;28:331-343.
78. Sack MN, Murphy E. The role of comorbidities in cardioprotection. J Cardiovasc Pharmacol Ther 2011;16:267-272.
79. Brunk UT, Terman A. The mitochondrial-lysosomal axis theory of aging: accumulation of damaged mitochondria as a result of imperfect autophagocytosis. Eur J Biochem 2002;269:1996-2002. (Pubitemid 34437840)
80. Gonzalez CD, Lee MS, Marchetti P, Pietropaolo M, Towns R, Vaccaro MI et al. The emerging role of autophagy in the pathophysiology of diabetes mellitus. Autophagy 2011;7:2-11.